title: Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Tsochatzis
authors.forename: Tim
authors.initials: T
authors.lastname: Meyer
authors.forename: James
authors.initials: J
authors.lastname: O'Beirne
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D035843:Biomedical Research / Q000379:methods / Q000458:organization & administration / Q000592:standards; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000379:methods* / Q000592:standards; D004621:Embolization, Therapeutic / Q000379:methods* / Q000592:standards; D005060:Europe; D019317:Evidence-Based Medicine / Q000592:standards; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D017410:Practice Guidelines as Topic / Q000592:standards; D015203:Reproducibility of Results